BusinessVaccinex, Inc. Announces Research Collaboration Employing ActivMAb® Platform Technology and Antibody License Option Agreement with Surface OncologyBy Nasdaq OMXJan 8, 2018, 6:10 PM UTC
BusinessAbCellera Announces Expanded Research Collaboration with TevaBy Nasdaq OMXJun 13, 2017, 1:00 PM UTC
BusinessAbCellera Announces Multi-Target Research Collaboration with PfizerBy Nasdaq OMXJan 5, 2017, 2:00 PM UTC
BusinessAbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic CandidatesBy Nasdaq OMXAug 24, 2016, 1:00 PM UTC
BusinessTeva and AbCellera Enter Into Agreement to Discover Rare Monoclonal AntibodiesBy Nasdaq OMXFeb 2, 2016, 1:00 PM UTC
BusinessAbCellera and Merck Sign Novel Therapeutic Antibody Discovery CollaborationBy Nasdaq OMXJan 27, 2016, 9:08 PM UTC
